ArticleAmerican journal of epidemiology2026
Assessing bias and precision in state policy evaluations: a comparative analysis of time-varying estimators using policy simulations.
Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Using state-level opioid overdose mortality data (1999-2016), we evaluated the performance of panel data estimators for capturing time-varying impacts of state-level policies. Most health policy evaluations assume static treatment effects, yet many interventions exhibit dynamic impacts, raising methodological questions about optimal estimation strategies. We simulated four time-varying treatment scenarios reflecting common policy dynamics (gradual increase, gradual decline, temporary effects, and inconsistent trajectories) and compared seven methods: two-way fixed effects event study, debiased autoregressive model, augmented synthetic control, difference in differences with staggered adoption, event study with heterogeneous treatment, two-stage differences in differences, and differences-in-differences imputation. Performance was assessed using bias, standard errors, coverage probability, and root mean squared error. Estimator performance varied substantially across scenarios. Augmented synthetic controls showed lower bias but higher variance when policy effectiveness diminished over time. Difference-in-difference approaches provided reasonable coverage in some scenarios but struggled with non-monotonic effects, while autoregressive methods exhibited lower variability but underestimated uncertainty. Overall, no single estimator performed best across settings. For epidemiological policy evaluations, particularly time-sensitive interventions like opioid-related policies, researchers should weigh bias-variance tradeoffs and align methodological choices with expected effect trajectories. Careful selection of analytic approaches is critical to avoid misattribution of policy effects and ensure valid conclusions about population health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.